{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:26:57Z","timestamp":1791581217205,"version":"4.3.4"},"reference-count":169,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["F30HD089577"],"award-info":[{"award-number":["F30HD089577"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI136556"],"award-info":[{"award-number":["R21AI136556"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI051355"],"award-info":[{"award-number":["R01AI051355"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT\/204870\/Z\/16\/Z"],"award-info":[{"award-number":["WT\/204870\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","award":["A1601"],"award-info":[{"award-number":["A1601"]}],"id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondazione Regionale per la Ricerca Biomedica-Regione Lombardia","award":["2015-0043"],"award-info":[{"award-number":["2015-0043"]}]},{"name":"Fondazione Regionale per la Ricerca Biomedica-Regione Lombardia","award":["R01AI051355"],"award-info":[{"award-number":["R01AI051355"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Human cytomegalovirus (HCMV) is the most common infectious cause of infant birth defects and an etiology of significant morbidity and mortality in solid organ and hematopoietic stem cell transplant recipients. There is tremendous interest in developing a vaccine or immunotherapeutic to reduce the burden of HCMV-associated disease, yet after nearly a half-century of research and development in this field we remain without such an intervention. Defining immune correlates of protection is a process that enables targeted vaccine\/immunotherapeutic discovery and informed evaluation of clinical performance. Outcomes in the HCMV field have previously been measured against a variety of clinical end points, including virus acquisition, systemic replication, and progression to disease. Herein we review immune correlates of protection against each of these end points in turn, showing that control of HCMV likely depends on a combination of innate immune factors, antibodies, and T-cell responses. Furthermore, protective immune responses are heterogeneous, with no single immune parameter predicting protection against all clinical outcomes and stages of HCMV infection. A detailed understanding of protective immune responses for a given clinical end point will inform immunogen selection and guide preclinical and clinical evaluation of vaccines or immunotherapeutics to prevent HCMV-mediated congenital and transplant disease.<\/jats:p>","DOI":"10.1093\/infdis\/jiz428","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T19:22:39Z","timestamp":1566501759000},"page":"S45-S59","source":"Crossref","is-referenced-by-count":47,"title":["Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease"],"prefix":"10.1093","volume":"221","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1046-455X","authenticated-orcid":false,"given":"Cody S","family":"Nelson","sequence":"first","affiliation":[{"name":"Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"Baraniak","sequence":"first","affiliation":[{"name":"Institute for Immunity and Transplantation, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Lilleri","sequence":"first","affiliation":[{"name":"Laboratory of Genetics, Transplantation, and Cardiovascular Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew B","family":"Reeves","sequence":"first","affiliation":[{"name":"Institute for Immunity and Transplantation, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D","family":"Griffiths","sequence":"first","affiliation":[{"name":"Institute for Immunity and Transplantation, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sallie R","family":"Permar","sequence":"first","affiliation":[{"name":"Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,3,5]]},"reference":[{"key":"2020030507495961500_CIT0001","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.pcl.2012.12.008","article-title":"Congenital cytomegalovirus infection: new prospects for prevention and therapy","volume":"60","author":"Swanson","year":"2013","journal-title":"Pediatr Clin North Am"},{"key":"2020030507495961500_CIT0002","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/CMR.00062-12","article-title":"The \u201csilent\u201d global burden of congenital cytomegalovirus","volume":"26","author":"Manicklal","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"2020030507495961500_CIT0003","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1086\/527397","article-title":"Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences","volume":"46","author":"Legendre","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2020030507495961500_CIT0004","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.hoc.2010.11.011","article-title":"Cytomegalovirus in hematopoietic stem cell transplant recipients","volume":"25","author":"Ljungman","year":"2011","journal-title":"Hematol Oncol Clin North Am"},{"key":"2020030507495961500_CIT0005","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.20050882","article-title":"Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects","volume":"202","author":"Sylwester","year":"2005","journal-title":"J Exp Med"},{"key":"2020030507495961500_CIT0006","doi-asserted-by":"crossref","first-page":"13585","DOI":"10.1073\/pnas.1735466100","article-title":"Reevaluation of human cytomegalovirus coding potential","volume":"100","author":"Murphy","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020030507495961500_CIT0007","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1128\/JVI.77.7.4326-4344.2003","article-title":"In silico pattern-based analysis of the human cytomegalovirus genome","volume":"77","author":"Rigoutsos","year":"2003","journal-title":"J Virol"},{"key":"2020030507495961500_CIT0008","doi-asserted-by":"crossref","first-page":"11881","DOI":"10.1128\/JVI.74.24.11881-11892.2000","article-title":"Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73)","volume":"74","author":"Mach","year":"2000","journal-title":"J Virol"},{"key":"2020030507495961500_CIT0009","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1128\/JVI.01251-08","article-title":"Human cytomegalovirus glycoprotein B is required for virus entry and cell-to-cell spread but not for virion attachment, assembly, or egress","volume":"83","author":"Isaacson","year":"2009","journal-title":"J Virol"},{"key":"2020030507495961500_CIT0010","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1128\/JVI.01970-10","article-title":"Rhesus and human cytomegalovirus glycoprotein L are required for infection and cell-to-cell spread of virus but cannot complement each other","volume":"85","author":"Bowman","year":"2011","journal-title":"J Virol"},{"key":"2020030507495961500_CIT0011","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.coviro.2012.01.001","article-title":"Human cytomegalovirus entry into cells","volume":"2","author":"Vanarsdall","year":"2012","journal-title":"Curr Opin Virol"},{"key":"2020030507495961500_CIT0012","doi-asserted-by":"crossref","first-page":"10023","DOI":"10.1128\/JVI.78.18.10023-10033.2004","article-title":"Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes","volume":"78","author":"Hahn","year":"2004","journal-title":"J Virol"},{"key":"2020030507495961500_CIT0013","doi-asserted-by":"crossref","first-page":"18153","DOI":"10.1073\/pnas.0509201102","article-title":"Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism","volume":"102","author":"Wang","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020030507495961500_CIT0014","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/cid\/cis238","article-title":"Nomenclature for immune correlates of protection after vaccination","volume":"54","author":"Plotkin","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2020030507495961500_CIT0015","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"Haynes","year":"2012","journal-title":"N Engl J Med"},{"key":"2020030507495961500_CIT0016","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"2020030507495961500_CIT0017","doi-asserted-by":"crossref","first-page":"515","DOI":"10.6061\/clinics\/2015(07)09","article-title":"Cytomegalovirus infection in transplant recipients","volume":"70","author":"Azevedo","year":"2015","journal-title":"Clinics (Sao Paulo)"},{"key":"2020030507495961500_CIT0018","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/rmv.659","article-title":"Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV","volume":"20","author":"Hyde","year":"2010","journal-title":"Rev Med Virol"},{"key":"2020030507495961500_CIT0019","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2334-7-71","article-title":"Incidence of cytomegalovirus infection among the general population and pregnant women in the United States","volume":"7","author":"Colugnati","year":"2007","journal-title":"BMC Infect Dis"},{"key":"2020030507495961500_CIT0020","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0264-410X(00)00377-7","article-title":"Encouraging prospects for immunisation against primary cytomegalovirus infection","volume":"19","author":"Griffiths","year":"2001","journal-title":"Vaccine"},{"key":"2020030507495961500_CIT0021","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/rmv.695","article-title":"Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection","volume":"21","author":"Cannon","year":"2011","journal-title":"Rev Med Virol"},{"key":"2020030507495961500_CIT0022","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/rmv.484","article-title":"Acquisition of human cytomegalovirus infection in infants via breast milk: natural immunization or cause for concern?","volume":"16","author":"Schleiss","year":"2006","journal-title":"Rev Med Virol"},{"key":"2020030507495961500_CIT0023","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/infdis\/jiw076","article-title":"Prospective characterization of the risk factors for transmission and symptoms of primary human herpesvirus infections among Ugandan infants","volume":"214","author":"Gantt","year":"2016","journal-title":"J Infect Dis"},{"key":"2020030507495961500_CIT0024","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1099\/jmm.0.027771-0","article-title":"Cytomegalovirus (CMV) shedding is highly correlated with markers of immunosuppression in CMV-seropositive women","volume":"60","author":"Schoenfisch","year":"2011","journal-title":"J Med Microbiol"},{"key":"2020030507495961500_CIT0025","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.4049\/jimmunol.172.5.3260","article-title":"Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children","volume":"172","author":"Tu","year":"2004","journal-title":"J Immunol"},{"key":"2020030507495961500_CIT0026","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1186\/s12879-014-0568-2","article-title":"Cross-sectional study of cytomegalovirus shedding and immunological markers among seropositive children and their mothers","volume":"14","author":"Stowell","year":"2014","journal-title":"BMC Infect Dis"},{"key":"2020030507495961500_CIT0027","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/cid\/ciy143","article-title":"Urinary cytomegalovirus shedding in the United States: the National Health and Nutrition Examination Surveys, 1999\u20132004","volume":"67","author":"Amin","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2020030507495961500_CIT0028","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/rmv.695","article-title":"Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection","volume":"21","author":"Cannon","year":"2011","journal-title":"Rev Med Virol"},{"key":"2020030507495961500_CIT0029","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10875-015-0139-3","article-title":"Reduced frequencies of polyfunctional CMV-specific T cell responses in infants with congenital CMV infection","volume":"35","author":"Gibson","year":"2015","journal-title":"J Clin Immunol"},{"key":"2020030507495961500_CIT0030","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/jpids\/piu089","article-title":"Longitudinal kinetics of cytomegalovirus-specific T-cell immunity and viral replication in infants with congenital cytomegalovirus infection","volume":"5","author":"Chen","year":"2016","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2020030507495961500_CIT0031","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-014-0568-2","article-title":"Cross-sectional study of cytomegalovirus shedding and immunological markers among seropositive children and their mothers","volume":"14","author":"Stowell","year":"2014","journal-title":"BMC Infect Dis"},{"key":"2020030507495961500_CIT0032","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/infdis\/174.2.387","article-title":"Mucosal antibodies to human cytomegalovirus glycoprotein B occur following both natural infection and immunization with human cytomegalovirus vaccines","volume":"174","author":"Wang","year":"1996","journal-title":"J Infect Dis"},{"key":"2020030507495961500_CIT0033","doi-asserted-by":"crossref","first-page":"e01695","DOI":"10.1128\/JVI.01695-18","article-title":"Intrahost dynamics of human cytomegalovirus variants acquired by seronegative glycoprotein B vaccinees","volume":"93","author":"Nelson","year":"2018","journal-title":"J Virol"},{"key":"2020030507495961500_CIT0034","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.coviro.2017.08.005","article-title":"Rhesus monkeys for a nonhuman primate model of cytomegalovirus infections","volume":"25","author":"Itell","year":"2017","journal-title":"Curr Opin Virol"},{"key":"2020030507495961500_CIT0035","doi-asserted-by":"crossref","first-page":"6620","DOI":"10.1128\/JVI.77.12.6620-6636.2003","article-title":"Complete sequence and genomic analysis of rhesus cytomegalovirus","volume":"77","author":"Hansen","year":"2003","journal-title":"J Virol"},{"key":"2020030507495961500_CIT0036","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/0192623308326095","article-title":"The macaque placenta\u2014a mini-review","volume":"36","author":"de Rijk","year":"2008","journal-title":"Toxicol Pathol"},{"key":"2020030507495961500_CIT0037","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0065-3527(08)00405-3","article-title":"Rhesus cytomegalovirus a nonhuman primate model for the study of human cytomegalovirus","volume":"72","author":"Yue","year":"2008","journal-title":"Adv Virus Res"},{"key":"2020030507495961500_CIT0038","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1006\/viro.2000.0195","article-title":"Primate cytomegaloviruses encode and express an IL-10-like protein","volume":"268","author":"Lockridge","year":"2000","journal-title":"Virology"},{"key":"2020030507495961500_CIT0039","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00430-007-0073-y","article-title":"Rhesus CMV: an emerging animal model for human CMV","volume":"197","author":"Powers","year":"2008","journal-title":"Med Microbiol Immunol"},{"key":"2020030507495961500_CIT0040","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1128\/JVI.01708-06","article-title":"Immunogenicity and protective efficacy of DNA vaccines expressing rhesus cytomegalovirus glycoprotein B, phosphoprotein 65-2, and viral interleukin-10 in rhesus macaques","volume":"81","author":"Yue","year":"2007","journal-title":"J Virol"},{"key":"2020030507495961500_CIT0041","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1128\/JVI.00883-10","article-title":"Vaccine-induced control of viral shedding following rhesus cytomegalovirus challenge in rhesus macaques","volume":"85","author":"Abel","year":"2011","journal-title":"J Virol"},{"key":"2020030507495961500_CIT0042","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.94002","article-title":"Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys","volume":"2","author":"Nelson","year":"2017","journal-title":"JCI Insight"},{"key":"2020030507495961500_CIT0043","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/rmv.484","article-title":"Acquisition of human cytomegalovirus infection in infants via breast milk: natural immunization or cause for concern?","volume":"16","author":"Schleiss","year":"2006","journal-title":"Rev Med Virol"},{"key":"2020030507495961500_CIT0044","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/adc.62.8.780","article-title":"Early acquisition of cytomegalovirus infection","volume":"62","author":"Peckham","year":"1987","journal-title":"Arch Dis Child"},{"key":"2020030507495961500_CIT0045","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/infdis\/jiw076","article-title":"Prospective characterization of the risk factors for transmission and symptoms of primary human herpesvirus infections among Ugandan infants","volume":"214","author":"Gantt","year":"2016","journal-title":"J Infect Dis"},{"key":"2020030507495961500_CIT0046","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1128\/CDLI.8.4.818-821.2001","article-title":"Viral load in breast milk correlates with transmission of human cytomegalovirus to preterm neonates, but lactoferrin concentrations do not","volume":"8","author":"van der Strate","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"2020030507495961500_CIT0047","doi-asserted-by":"crossref","first-page":"e153785","DOI":"10.1001\/jamapediatrics.2015.3785","article-title":"Postnatal cytomegalovirus infection and the risk for bronchopulmonary dysplasia","volume":"169","author":"Kelly","year":"2015","journal-title":"JAMA Pediatr"},{"key":"2020030507495961500_CIT0048","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jcv.2007.12.005","article-title":"Cytomegalovirus transmission to preterm infants during lactation","volume":"41","author":"Hamprecht","year":"2008","journal-title":"J Clin Virol"},{"key":"2020030507495961500_CIT0049","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1056\/NEJM198005083021908","article-title":"Breast milk and the risk of cytomegalovirus infection","volume":"302","author":"Stagno","year":"1980","journal-title":"N Engl J Med"},{"key":"2020030507495961500_CIT0050","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/infdis\/jix457","article-title":"Breast milk human cytomegalovirus (CMV) viral load and the establishment of breast milk CMV-pp65-specific CD8 T cells in human CMV infected mothers","volume":"216","author":"Moylan","year":"2017","journal-title":"J Infect Dis"},{"key":"2020030507495961500_CIT0051","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.virusres.2010.10.031","article-title":"Human cytomegalovirus immunity and immune evasion","volume":"157","author":"Jackson","year":"2011","journal-title":"Virus Res"},{"key":"2020030507495961500_CIT0052","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0046-8177(84)80076-3","article-title":"Widespread presence of histologically occult cytomegalovirus","volume":"15","author":"Myerson","year":"1984","journal-title":"Hum Pathol"},{"key":"2020030507495961500_CIT0053","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa0804749","article-title":"Vaccine prevention of maternal cytomegalovirus infection","volume":"360","author":"Pass","year":"2009","journal-title":"N Engl J Med"},{"key":"2020030507495961500_CIT0054","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00380-17","article-title":"Transient oral human cytomegalovirus infections indicate inefficient viral spread from very few initially infected cells","volume":"91","author":"Mayer","year":"2017","journal-title":"J Virol"},{"key":"2020030507495961500_CIT0055","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.vaccine.2015.11.056","article-title":"Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: a randomized clinical trial","volume":"34","author":"Bernstein","year":"2016","journal-title":"Vaccine"},{"key":"2020030507495961500_CIT0056","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41541-018-0074-4","article-title":"A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infection","volume":"3","author":"Nelson","year":"2018","journal-title":"NPJ Vaccines"},{"key":"2020030507495961500_CIT0057","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jcv.2009.07.002","article-title":"Development and evidence for efficacy of CMV glycoprotein B vaccine with MF59 adjuvant","volume":"46","author":"Pass","year":"2009","journal-title":"J Clin Virol"},{"key":"2020030507495961500_CIT0058","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1073\/pnas.1800177115","article-title":"HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions","volume":"115","author":"Nelson","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020030507495961500_CIT0059","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1073\/pnas.1800224115","article-title":"Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies","volume":"115","author":"Baraniak","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020030507495961500_CIT0060","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1086\/339329","article-title":"Definitions of cytomegalovirus infection and disease in transplant recipients","volume":"34","author":"Ljungman","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2020030507495961500_CIT0061","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00281-014-0449-1","article-title":"Models of vertical cytomegalovirus (CMV) transmission and pathogenesis","volume":"36","author":"Weisblum","year":"2014","journal-title":"Semin Immunopathol"},{"key":"2020030507495961500_CIT0062","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jcv.2003.09.012","article-title":"Pathogenesis and prenatal diagnosis of human cytomegalovirus infection","volume":"29","author":"Revello","year":"2004","journal-title":"J Clin Virol"},{"key":"2020030507495961500_CIT0063","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.placenta.2017.04.011","article-title":"Maternal immune correlates of protection against placental transmission of cytomegalovirus","volume":"60","author":"Itell","year":"2017","journal-title":"Placenta"},{"key":"2020030507495961500_CIT0064","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1146\/annurev-virology-031413-085524","article-title":"The placenta as a barrier to viral infections","volume":"1","author":"Delorme-Axford","year":"2014","journal-title":"Annu Rev Virol"},{"key":"2020030507495961500_CIT0065","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/(SICI)1096-9071(199906)58:2<182::AID-JMV14>3.0.CO;2-Q","article-title":"Quantity of human cytomegalovirus (CMV) DNAemia as a risk factor for CMV disease in renal allograft recipients: relationship with donor\/recipient CMV serostatus, receipt of augmented methylprednisolone and antithymocyte globulin (ATG)","volume":"58","author":"Hassan-Walker","year":"1999","journal-title":"J Med Virol"},{"key":"2020030507495961500_CIT0066","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/jmv.1890310309","article-title":"Relation of maternal CMV viremia and antibody response to the rate of congenital infection and intrauterine growth retardation","volume":"31","author":"Harrison","year":"1990","journal-title":"J Med Virol"},{"key":"2020030507495961500_CIT0067","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/infdis\/171.5.1115","article-title":"Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection","volume":"171","author":"Boppana","year":"1995","journal-title":"J Infect Dis"},{"key":"2020030507495961500_CIT0068","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1093\/infdis\/jiw487","article-title":"Maternal antibody responses and nonprimary congenital cytomegalovirus infection of HIV-1-exposed infants","volume":"214","author":"Bialas","year":"2016","journal-title":"J Infect Dis"},{"key":"2020030507495961500_CIT0069","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01794-16","article-title":"Phase 2 randomized, double-blind, placebo-controlled trial of RG7667, a combination monoclonal antibody, for prevention of cytomegalovirus infection in high-risk kidney transplant recipients","volume":"61","author":"Ishida","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2020030507495961500_CIT0070","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/jmv.25225","article-title":"Human cytomegalovirus (HCMV)-specific T cell but not neutralizing or IgG binding antibody responses to glycoprotein complexes gB, gHgLgO, and pUL128L correlate with protection against high HCMV viral load reactivation in solid-organ transplant recipients","volume":"90","author":"Lilleri","year":"2018","journal-title":"J Med Virol"},{"key":"2020030507495961500_CIT0071","doi-asserted-by":"crossref","first-page":"a007278","DOI":"10.1101\/cshperspect.a007278","article-title":"Rational design of vaccines to elicit broadly neutralizing antibodies to HIV-1","volume":"1","author":"Kwong","year":"2011","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2020030507495961500_CIT0072","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1099\/0022-1317-83-9-2091","article-title":"Occupancy and mechanism in antibody-mediated neutralization of animal viruses","volume":"83","author":"Klasse","year":"2002","journal-title":"J Gen Virol"},{"key":"2020030507495961500_CIT0073","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.1073\/pnas.1704809114","article-title":"The pentameric complex drives immunologically covert cell-cell transmission of wild-type human cytomegalovirus","volume":"114","author":"Murrell","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020030507495961500_CIT0074","doi-asserted-by":"crossref","DOI":"10.3390\/v11030221","article-title":"Inclusion of antibodies to cell culture media preserves the integrity of genes encoding RL13 and the pentameric complex components during fibroblast passage of human cytomegalovirus","volume":"11","author":"Ourahmane","year":"2019","journal-title":"Viruses"},{"key":"2020030507495961500_CIT0075","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.virol.2013.06.002","article-title":"Neutralizing antibodies are unable to inhibit direct viral cell-to-cell spread of human cytomegalovirus","volume":"444","author":"Jacob","year":"2013","journal-title":"Virology"},{"key":"2020030507495961500_CIT0076","doi-asserted-by":"crossref","first-page":"e1006601","DOI":"10.1371\/journal.ppat.1006601","article-title":"Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus","volume":"13","author":"Bootz","year":"2017","journal-title":"PLoS Pathog"},{"key":"2020030507495961500_CIT0077","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0140-6736(11)60136-0","article-title":"Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial","volume":"377","author":"Griffiths","year":"2011","journal-title":"Lancet"},{"key":"2020030507495961500_CIT0078","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1093\/infdis\/jiy102","article-title":"Epitope-specific humoral responses to human cytomegalovirus glycoprotein-B vaccine with MF59: anti-AD2 levels correlate with protection from viremia","volume":"217","author":"Baraniak","year":"2018","journal-title":"J Infect Dis"},{"key":"2020030507495961500_CIT0079","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jcv.2014.07.020","article-title":"Human cytomegalovirus quantification in toddlers saliva from day care centers and emergency unit: a feasibility study","volume":"61","author":"Grosjean","year":"2014","journal-title":"J Clin Virol"},{"key":"2020030507495961500_CIT0080","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jcv.2009.08.018","article-title":"Direct genotyping of cytomegalovirus envelope glycoproteins from toddler's saliva samples","volume":"46","author":"Grosjean","year":"2009","journal-title":"J Clin Virol"},{"key":"2020030507495961500_CIT0081","doi-asserted-by":"crossref","first-page":"e59863","DOI":"10.1371\/journal.pone.0059863","article-title":"Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH\/gL\/pUL128-130-131 complex during primary infection","volume":"8","author":"Lilleri","year":"2013","journal-title":"PLoS One"},{"key":"2020030507495961500_CIT0082","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1073\/pnas.1814835116","article-title":"HCMV trimer- and pentamer-specific antibodies synergize for virus neutralization but do not correlate with congenital transmission","volume":"116","author":"Vanarsdall","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020030507495961500_CIT0083","doi-asserted-by":"crossref","first-page":"e0194789","DOI":"10.1371\/journal.pone.0194789","article-title":"Levels of anti-CMV antibodies are modulated by the frequency and intensity of virus reactivations in kidney transplant patients","volume":"13","author":"Iglesias-Escudero","year":"2018","journal-title":"PLoS One"},{"key":"2020030507495961500_CIT0084","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jcv.2015.01.004","article-title":"Primary human cytomegalovirus infections: kinetics of ELISA-IgG and neutralizing antibody in pauci\/asymptomatic pregnant women vs symptomatic non-pregnant subjects","volume":"64","author":"Fornara","year":"2015","journal-title":"J Clin Virol"},{"key":"2020030507495961500_CIT0085","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJMoa1310214","article-title":"A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus","volume":"370","author":"Revello","year":"2014","journal-title":"N Engl J Med"},{"key":"2020030507495961500_CIT0086","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/uog.19164","article-title":"Prevention\u2009of\u2009maternal-fetal\u2009transmission\u2009of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administration","volume":"53","author":"Kagan","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2020030507495961500_CIT0087","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/TP.0b013e318224115e","article-title":"Cytomegalovirus neutralization by hyperimmune and standard intravenous immunoglobulin preparations","volume":"92","author":"Planitzer","year":"2011","journal-title":"Transplantation"},{"key":"2020030507495961500_CIT0088","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2353\/ajpath.2006.050482","article-title":"Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis","volume":"168","author":"Maidji","year":"2006","journal-title":"Am J Pathol"},{"key":"2020030507495961500_CIT0089","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000487302","article-title":"Histological analysis of term placentas from hyperimmune globulin-treated and untreated mothers with primary cytomegalovirus infection","volume":"45","author":"Gabrielli","year":"2019","journal-title":"Fetal Diagn Ther"},{"key":"2020030507495961500_CIT0090","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.humimm.2004.02.020","article-title":"Properties of CD4+ T cells in human cytomegalovirus infection","volume":"65","author":"Gamadia","year":"2004","journal-title":"Hum Immunol"},{"key":"2020030507495961500_CIT0091","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1099\/vir.0.070441-0","article-title":"Differential kinetics of human cytomegalovirus load and antibody responses in primary infection of the immunocompetent and immunocompromised host","volume":"96","author":"Gerna","year":"2015","journal-title":"J Gen Virol"},{"key":"2020030507495961500_CIT0092","doi-asserted-by":"crossref","first-page":"e3634","DOI":"10.1371\/journal.pone.0003634","article-title":"Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation","volume":"3","author":"Widmann","year":"2008","journal-title":"PLoS One"},{"key":"2020030507495961500_CIT0093","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1086\/512245","article-title":"Development of human cytomegalovirus-specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus","volume":"195","author":"Lilleri","year":"2007","journal-title":"J Infect Dis"},{"key":"2020030507495961500_CIT0094","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1086\/498872","article-title":"Lymphoproliferative response in primary human cytomegalovirus (HCMV) infection is delayed in HCMV transmitter mothers","volume":"193","author":"Revello","year":"2006","journal-title":"J Infect Dis"},{"key":"2020030507495961500_CIT0095","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/cid\/civ561","article-title":"Strong cell-mediated immune response to human cytomegalovirus is associated with increased risk of fetal infection in primarily infected pregnant women","volume":"61","author":"Saldan","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2020030507495961500_CIT0096","doi-asserted-by":"crossref","first-page":"e0187731","DOI":"10.1371\/journal.pone.0187731","article-title":"Phenotype and specificity of T cells in primary human cytomegalovirus infection during pregnancy: IL-7Rpos long-term memory phenotype is associated with protection from vertical transmission","volume":"12","author":"Mele","year":"2017","journal-title":"PLoS One"},{"key":"2020030507495961500_CIT0097","doi-asserted-by":"crossref","first-page":"13645","DOI":"10.1073\/pnas.1511526112","article-title":"Maternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission","volume":"112","author":"Bialas","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020030507495961500_CIT0098","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00510-16","article-title":"Plasmablast response to primary rhesus cytomegalovirus (CMV) infection in a monkey model of congenital CMV transmission","volume":"24","author":"Fan","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"2020030507495961500_CIT0099","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1600-6143.2008.02191.x","article-title":"Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation","volume":"8","author":"Mattes","year":"2008","journal-title":"Am J Transplant"},{"key":"2020030507495961500_CIT0100","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1086\/323354","article-title":"Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants","volume":"184","author":"Aubert","year":"2001","journal-title":"J Infect Dis"},{"key":"2020030507495961500_CIT0101","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1084\/jem.20042408","article-title":"Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease","volume":"201","author":"Sacre","year":"2005","journal-title":"J Exp Med"},{"key":"2020030507495961500_CIT0102","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1084\/jem.188.6.1047","article-title":"Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection","volume":"188","author":"Poli\u0107","year":"1998","journal-title":"J Exp Med"},{"key":"2020030507495961500_CIT0103","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S1473-3099(11)70344-9","article-title":"A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"12","author":"Kharfan-Dabaja","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"2020030507495961500_CIT0104","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1164\/rccm.201504-0733OC","article-title":"Polyfunctional T-cell signatures to predict protection from cytomegalovirus after lung transplantation","volume":"193","author":"Snyder","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2020030507495961500_CIT0105","doi-asserted-by":"crossref","first-page":"e1005868","DOI":"10.1371\/journal.ppat.1005868","article-title":"Natural killer cell evasion is essential for infection by rhesus cytomegalovirus","volume":"12","author":"Sturgill","year":"2016","journal-title":"PLoS Pathog"},{"key":"2020030507495961500_CIT0106","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.immuni.2015.09.013","article-title":"Natural killer cell memory","volume":"43","author":"O'Sullivan","year":"2015","journal-title":"Immunity"},{"key":"2020030507495961500_CIT0107","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.4049\/jimmunol.1201964","article-title":"Human cytomegalovirus (CMV)-induced memory-like NKG2C+ NK cells are transplantable and expand in vivo in response to recipient CMV antigen","volume":"189","author":"Foley","year":"2012","journal-title":"J Immunol"},{"key":"2020030507495961500_CIT0108","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4049\/jimmunol.1601236","article-title":"Adaptive NKG2C+ NK cell response and the risk of cytomegalovirus infection in kidney transplant recipients","volume":"198","author":"Redondo-Pach\u00f3n","year":"2017","journal-title":"J Immunol"},{"key":"2020030507495961500_CIT0109","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.4049\/jimmunol.1302053","article-title":"Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C\u2212\/\u2212 umbilical cord blood","volume":"192","author":"Della Chiesa","year":"2014","journal-title":"J Immunol"},{"key":"2020030507495961500_CIT0110","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a029538","article-title":"Is there natural killer cell memory and can it be harnessed by vaccination? NK cell memory and immunization strategies against infectious diseases and cancer","volume":"10","author":"Sun","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2020030507495961500_CIT0111","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1073\/pnas.0409597102","article-title":"Human cytomegalovirus cell-to-cell spread in the absence of an essential assembly protein","volume":"102","author":"Silva","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020030507495961500_CIT0112","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1128\/JVI.00121-16","article-title":"Monoclonal antibodies to different components of the human cytomegalovirus (HCMV) pentamer gH\/gL\/pUL128L and trimer gH\/gL\/gO as well as antibodies elicited during primary HCMV infection prevent epithelial cell syncytium formation","volume":"90","author":"Gerna","year":"2016","journal-title":"J Virol"},{"key":"2020030507495961500_CIT0113","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1034\/j.1399-3062.2001.00006.x","article-title":"Antibody inhibition of cytomegalovirus: the role of natural killer and macrophage effector cells","volume":"3","author":"Forthal","year":"2001","journal-title":"Transpl Infect Dis"},{"key":"2020030507495961500_CIT0114","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1084\/jem.20160758","article-title":"Tissue reservoirs of antiviral T cell immunity in persistent human CMV infection","volume":"214","author":"Gordon","year":"2017","journal-title":"J Exp Med"},{"key":"2020030507495961500_CIT0115","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1126\/science.1058867","article-title":"Preferential localization of effector memory cells in nonlymphoid tissue","volume":"291","author":"Masopust","year":"2001","journal-title":"Science"},{"key":"2020030507495961500_CIT0116","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.4049\/jimmunol.172.8.4875","article-title":"Activated primary and memory CD8 T cells migrate to nonlymphoid tissues regardless of site of activation or tissue of origin","volume":"172","author":"Masopust","year":"2004","journal-title":"J Immunol"},{"key":"2020030507495961500_CIT0117","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1002\/eji.200526004","article-title":"Novel phenotypes and migratory properties distinguish memory CD4 T cell subsets in lymphoid and lung tissue","volume":"35","author":"Bingaman","year":"2005","journal-title":"Eur J Immunol"},{"key":"2020030507495961500_CIT0118","doi-asserted-by":"crossref","first-page":"17872","DOI":"10.1073\/pnas.1010201107","article-title":"Memory T cells persisting within the brain after local infection show functional adaptations to their tissue of residence","volume":"107","author":"Wakim","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020030507495961500_CIT0119","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.it.2007.08.009","article-title":"Do most lymphocytes in humans really reside in the gut?","volume":"28","author":"Ganusov","year":"2007","journal-title":"Trends Immunol"},{"key":"2020030507495961500_CIT0120","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nri.2016.34","article-title":"Emerging insights into natural killer cells in human peripheral tissues","volume":"16","author":"Bj\u00f6rkstr\u00f6m","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"2020030507495961500_CIT0121","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0143-4004(96)80070-1","article-title":"Granulated lymphocytes of pregnancy","volume":"17","author":"Whitelaw","year":"1996","journal-title":"Placenta"},{"key":"2020030507495961500_CIT0122","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3389\/fimmu.2013.00404","article-title":"Human decidual NK cells: unique and tightly regulated effector functions in healthy and pathogen-infected pregnancies","volume":"4","author":"Le Bouteiller","year":"2013","journal-title":"Front Immunol"},{"key":"2020030507495961500_CIT0123","doi-asserted-by":"crossref","first-page":"e1003257","DOI":"10.1371\/journal.ppat.1003257","article-title":"Human cytomegalovirus infection elicits new decidual natural killer cell effector functions","volume":"9","author":"Siewiera","year":"2013","journal-title":"PLoS Pathog"},{"key":"2020030507495961500_CIT0124","doi-asserted-by":"crossref","first-page":"15072","DOI":"10.1073\/pnas.1617927114","article-title":"Expression of KIR2DS1 by decidual natural killer cells increases their ability to control placental HCMV infection","volume":"113","author":"Crespo","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020030507495961500_CIT0125","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3389\/fimmu.2018.00781","article-title":"Natural killer cell recruitment to the lung during influenza A virus infection is dependent on CXCR3, CCR5, and virus exposure dose","volume":"9","author":"Carlin","year":"2018","journal-title":"Front Immunol"},{"key":"2020030507495961500_CIT0126","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1128\/JVI.03030-12","article-title":"Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques","volume":"87","author":"Jegaskanda","year":"2013","journal-title":"J Virol"},{"key":"2020030507495961500_CIT0127","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/eji.201242620","article-title":"NK cells exacerbate the pathology of influenza virus infection in mice","volume":"43","author":"Zhou","year":"2013","journal-title":"Eur J Immunol"},{"key":"2020030507495961500_CIT0128","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1084\/jem.20061287","article-title":"Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage","volume":"204","author":"Dunn","year":"2007","journal-title":"J Exp Med"},{"key":"2020030507495961500_CIT0129","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.1097670","article-title":"HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection","volume":"305","author":"Khakoo","year":"2004","journal-title":"Science"},{"key":"2020030507495961500_CIT0130","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1056\/NEJM198710223171703","article-title":"Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients","volume":"317","author":"Snydman","year":"1987","journal-title":"N Engl J Med"},{"key":"2020030507495961500_CIT0131","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1399-3062.2011.00664.x","article-title":"The association between cytomegalovirus immune globulin and long-term recipient and graft survival following liver transplantation","volume":"14","author":"Fisher","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"2020030507495961500_CIT0132","doi-asserted-by":"crossref","first-page":"E455","DOI":"10.1111\/j.1399-0012.2011.01459.x","article-title":"The impact of CMV prevention on long-term recipient and graft survival in heart transplant recipients: analysis of the Scientific Registry of Transplant Recipients (SRTR) database","volume":"25","author":"Snydman","year":"2011","journal-title":"Clin Transplant"},{"key":"2020030507495961500_CIT0133","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1399-0012.2007.00750.x","article-title":"CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis","volume":"22","author":"Bonaros","year":"2008","journal-title":"Clin Transplant"},{"key":"2020030507495961500_CIT0134","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/cid\/cis423","article-title":"Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age","volume":"55","author":"Visentin","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2020030507495961500_CIT0135","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.2353\/ajpath.2010.091210","article-title":"Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection","volume":"177","author":"Maidji","year":"2010","journal-title":"Am J Pathol"},{"key":"2020030507495961500_CIT0136","doi-asserted-by":"crossref","first-page":"S174","DOI":"10.1093\/cid\/cit583","article-title":"Cytomegalovirus infection and antibody protection of the developing placenta","volume":"57","author":"Pereira","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2020030507495961500_CIT0137","doi-asserted-by":"crossref","first-page":"G38","DOI":"10.1016\/j.vaccine.2009.09.105","article-title":"Monoclonal antibody-based therapies for microbial diseases","volume":"27","author":"Saylor","year":"2009","journal-title":"Vaccine"},{"key":"2020030507495961500_CIT0138","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1083-8791(01)80005-7","article-title":"Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Boeckh","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"2020030507495961500_CIT0139","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.antiviral.2004.06.012","article-title":"A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitis","volume":"64","author":"Borucki","year":"2004","journal-title":"Antiviral Res"},{"key":"2020030507495961500_CIT0140","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.chom.2011.07.010","article-title":"Human cytomegalovirus escapes a naturally occurring neutralizing antibody by incorporating it into assembling virions","volume":"10","author":"Manley","year":"2011","journal-title":"Cell Host Microbe"},{"key":"2020030507495961500_CIT0141","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1084\/jem.20042384","article-title":"Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells","volume":"201","author":"Bunde","year":"2005","journal-title":"J Exp Med"},{"key":"2020030507495961500_CIT0142","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.trim.2008.11.002","article-title":"High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function","volume":"20","author":"Nickel","year":"2009","journal-title":"Transpl Immunol"},{"key":"2020030507495961500_CIT0143","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1093\/infdis\/jir624","article-title":"Primary cytomegalovirus phosphoprotein 65-specific CD8+ T-cell responses and T-bet levels predict immune control during early chronic infection in lung transplant recipients","volume":"204","author":"Pipeling","year":"2011","journal-title":"J Infect Dis"},{"key":"2020030507495961500_CIT0144","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/jac\/dkl049","article-title":"Cytomegalovirus (CMV)-specific CD8+ T cells in individuals with HIV infection: correlation with protection from CMV disease","volume":"57","author":"Stone","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"2020030507495961500_CIT0145","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/cyto.b.20420","article-title":"Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations","volume":"74","author":"Gratama","year":"2008","journal-title":"Cytometry B Clin Cytom"},{"key":"2020030507495961500_CIT0146","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1128\/JVI.77.9.5226-5240.2003","article-title":"Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers","volume":"77","author":"Elkington","year":"2003","journal-title":"J Virol"},{"key":"2020030507495961500_CIT0147","doi-asserted-by":"crossref","first-page":"e106044","DOI":"10.1371\/journal.pone.0106044","article-title":"Human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells are both required for prevention of HCMV disease in seropositive solid-organ transplant recipients","volume":"9","author":"Gabanti","year":"2014","journal-title":"PLoS One"},{"key":"2020030507495961500_CIT0148","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fimmu.2017.00105","article-title":"\u03b3\u03b4 T cell-mediated immunity to cytomegalovirus infection","volume":"8","author":"Khairallah","year":"2017","journal-title":"Front Immunol"},{"key":"2020030507495961500_CIT0149","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1172\/JCI5409","article-title":"Implication of \u03b3\u03b4 T cells in the human immune response to cytomegalovirus","volume":"103","author":"D\u00e9chanet","year":"1999","journal-title":"J Clin Invest"},{"key":"2020030507495961500_CIT0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/314568","article-title":"Major expansion of \u03b3\u03b4 T lymphocytes following cytomegalovirus infection in kidney allograft recipients","volume":"179","author":"D\u00e9chanet","year":"1999","journal-title":"J Infect Dis"},{"key":"2020030507495961500_CIT0151","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1086\/322843","article-title":"Cytomegalovirus infection in transplant recipients resolves when circulating \u03b3\u03b4 T lymphocytes expand, suggesting a protective antiviral role","volume":"184","author":"Lafarge","year":"2001","journal-title":"J Infect Dis"},{"key":"2020030507495961500_CIT0152","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1111\/j.1432-2277.2010.01181.x","article-title":"Gamma-delta T cell expansion is closely associated with cytomegalovirus infection in all solid organ transplant recipients","volume":"24","author":"Couzi","year":"2011","journal-title":"Transpl Int"},{"key":"2020030507495961500_CIT0153","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1182\/blood-2010-01-255166","article-title":"The role of V\u03b42-negative \u03b3\u03b4 T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation","volume":"116","author":"Knight","year":"2010","journal-title":"Blood"},{"key":"2020030507495961500_CIT0154","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/leu.2012.374","article-title":"\u03b3\u03b4T cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia","volume":"27","author":"Scheper","year":"2013","journal-title":"Leukemia"},{"key":"2020030507495961500_CIT0155","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1007\/s10875-011-9577-8","article-title":"Kinetics of effector functions and phenotype of virus-specific and \u03b3\u03b4 T lymphocytes in primary human cytomegalovirus infection during pregnancy","volume":"31","author":"Fornara","year":"2011","journal-title":"J Clin Immunol"},{"key":"2020030507495961500_CIT0156","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1084\/jem.20090348","article-title":"Human cytomegalovirus elicits fetal \u03b3\u03b4 T cell responses in utero","volume":"207","author":"Vermijlen","year":"2010","journal-title":"J Exp Med"},{"key":"2020030507495961500_CIT0157","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1681\/ASN.2014100985","article-title":"Surveillance of \u03b3\u03b4 T cells predicts cytomegalovirus infection resolution in kidney transplants","volume":"27","author":"Kaminski","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"2020030507495961500_CIT0158","doi-asserted-by":"crossref","first-page":"e1004481","DOI":"10.1371\/journal.ppat.1004481","article-title":"Control of murine cytomegalovirus infection by \u03b3\u03b4 T cells","volume":"11","author":"Sell","year":"2015","journal-title":"PLoS Pathog"},{"key":"2020030507495961500_CIT0159","doi-asserted-by":"crossref","first-page":"e1004702","DOI":"10.1371\/journal.ppat.1004702","article-title":"\u03b3\u03b4 T cells confer protection against murine cytomegalovirus (MCMV)","volume":"11","author":"Khairallah","year":"2015","journal-title":"PLoS Pathog"},{"key":"2020030507495961500_CIT0160","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1681\/ASN.2013101052","article-title":"Cytomegalovirus-responsive \u03b3\u03b4 T cells: novel effector cells in antibody-mediated kidney allograft microcirculation lesions","volume":"25","author":"Bachelet","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"2020030507495961500_CIT0161","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fimmu.2015.00003","article-title":"Direct and indirect effects of cytomegalovirus-induced \u03b3\u03b4 T cells after kidney transplantation","volume":"6","author":"Couzi","year":"2015","journal-title":"Front Immunol"},{"key":"2020030507495961500_CIT0162","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/00007890-201407151-00543","article-title":"NK cell immunity pre-transplant as a predictor for CMV post-transplant: abstract# 2167","volume":"98","author":"Keshwani","year":"2014","journal-title":"Transplantation"},{"key":"2020030507495961500_CIT0163","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fimmu.2017.00166","article-title":"Dual role of natural killer cells on graft rejection and control of cytomegalovirus infection in renal transplantation","volume":"8","author":"L\u00f3pez-Botet","year":"2017","journal-title":"Front Immunol"},{"key":"2020030507495961500_CIT0164","doi-asserted-by":"crossref","first-page":"e1006599","DOI":"10.1371\/journal.ppat.1006599","article-title":"Natural killer cells attenuate cytomegalovirus-induced hearing loss in mice","volume":"13","author":"Almishaal","year":"2017","journal-title":"PLoS Pathog"},{"key":"2020030507495961500_CIT0165","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1126\/science.1185350","article-title":"Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus","volume":"328","author":"Hansen","year":"2010","journal-title":"Science"},{"key":"2020030507495961500_CIT0166","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s40265-016-0653-5","article-title":"Cytomegalovirus vaccines: current status and future prospects","volume":"76","author":"Anderholm","year":"2016","journal-title":"Drugs"},{"key":"2020030507495961500_CIT0167","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S2055-6640(20)30872-4","article-title":"Cytomegalovirus vaccines under clinical development","volume":"2","author":"Schleiss","year":"2016","journal-title":"J Virus Erad"},{"key":"2020030507495961500_CIT0168","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02392-16","article-title":"Congenital human cytomegalovirus infection and the enigma of maternal immunity","volume":"91","author":"Britt","year":"2017","journal-title":"J Virol"},{"key":"2020030507495961500_CIT0169","doi-asserted-by":"crossref","first-page":"e1986","DOI":"10.1002\/rmv.1986","article-title":"Cytomegalovirus vaccine: timing is important","volume":"28","author":"Griffiths","year":"2018","journal-title":"Rev Med Virol"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/221\/Supplement_1\/S45\/32791268\/jiz428.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/221\/Supplement_1\/S45\/32791268\/jiz428.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T12:03:23Z","timestamp":1721649803000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/221\/Supplement_1\/S45\/5781891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,5]]},"references-count":169,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2020,3,5]]},"published-print":{"date-parts":[[2020,3,5]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiz428","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,3,15]]},"published":{"date-parts":[[2020,3,5]]}}}